COVID-19 Vaccines, Prior Infection Reduce Transmission of Omicron
California prisons saw more than 20,000 COVID-19 Omicron cases over a five-month period. However, vaccination and boosting kept hospitalization and death rates low.
University of California San Francisco
Give to UCSFCalifornia prisons saw more than 20,000 COVID-19 Omicron cases over a five-month period. However, vaccination and boosting kept hospitalization and death rates low.
The California Collaborative for Pandemic Recovery and Readiness Research (CPR3) at UCSF will investigate the effects of the pandemic on California communities and individuals.
Since March 2020, UCSF has partnered with government and community groups to address racial, economic and cultural barriers to provide equitable care to vulnerable people during the COVID-19 pandemic.
38 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.
A low-cost, prenatal intervention benefits mothers’ mental health up to eight years later, a new UCSF study finds.
UCSF Experts Present Research at the Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Francisco.
Risk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
E-cigarettes and marijuana have similar harmful effects on the heart as tobacco cigarettes, opening the door to abnormal heart rhythms, reports a team of researchers at UCSF.
A $147 million grant will expand diversity among Alzheimer’s disease research participants, and involve partners from UCSF, the San Francisco VA Medical Center, and the Northern California Institute for Research and Education.
A third of American women of reproductive age now face excessive travel times to obtain an abortion, according to a new geospatial analysis by researchers in San Francisco and Boston that is one of the first to model the effects of the Supreme Court’s recent Dobbs v. Jackson decision.
Nevan Krogan, PhD, director of UC San Francisco’s (UCSF) Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
Nevan Krogan, PhD, director UCSF’s Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
A new diagnostic method that applies machine learning to advanced genomics data from both microbe and host to identify and predict sepsis cases was developed by researchers at UCSF, the Chan Zuckerberg Initiative, and CZ Biohub.
Cystic fibrosis is missed more often in newborn screenings for non-white than white babies, creating higher risk for irreversible lung damage and other serious outcomes in Black, Hispanic, Asian, American Indian and Alaska Native newborns.
A new UCSF study researchers of more than 23 million people concludes that some commonly used and abused drugs pose previously unidentified risks for the development of atrial fibrillation (AF), a potentially deadly heart-rhythm disorder.
Three UCSF faculty members are among the 100 new national members elected this year to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.
Not all senescent cells are harmful “zombies” that should be wiped out to prevent age-related disease. New research from UCSF found that some of them are embedded in young, healthy tissues and promote normal repair from damage.
A new study points to another persistent effect of COVID-19, identified months after infection: reduced exercise capacity.
A national online survey revealed American voters overwhelmingly say they want government and industry to ensure the products they buy are free of harmful chemicals, and they are willing to pay more for it.
Last month new “bivalent” booster vaccines made by Moderna and Pfizer became available that protect against currently circulating Omicron variants as well as earlier strains of the SARS-CoV-2 virus that causes COVID-19. This Q&A features Joel Ernst, MD, a UCSF professor of medicine whose research aims to understand how pathogens evade the immune system.